In July this year, some employees at the National Institute
for Health (NIH) in Bethesda Maryland came across something startling when they
were cleaning out an old storeroom.
They found a half-dozen vials of variola, also known as the smallpox
virus, from the 1950s. Smallpox is
one of the deadliest and most infectious diseases on the planet. These samples were sent to the CDC
(Center for Disease Control) in Atlanta to be tested, and as it turns out, they
were indeed active. That’s a
little disturbing. After being
confirmed active, the samples were destroyed in the presence of WHO (World
Health Organization) officials.
Sounds like there are some trust issues.
But who can blame them for not trusting us? After all, the CDC has maintained a large cache of variola samples against the WHO recommendation. These two organizations are on opposite sides of a decades long debate that has just been reignited -- Should all known samples of smallpox be destroyed or not?
The United States should not destroy its stock of variola,
the viral pathogen that causes smallpox, but maybe not for the reasons you
think.
Those on one side of the fence argue that the risk
associated with maintaining the deadly virus is greater than the potential
benefits from it. Accidents pose
the primary risk, though theft and weaponization are a concern, albeit
farfetched given the security levels at the CDC and at the Russian State
Research Center for Virology and Biotechnology in Koltsovo, where the only
other known stock is. That
argument will always be there, unless we make it a common practice to vaccinate
populations against smallpox again, but that seems unlikely.
Unfortunately, destroying the two remaining known stocks of variola is not the same
as destroying all remaining variola,
just as the rediscovery of those long forgotten vials at the NIH iterates. The security provided by destroying
them is only psychological. There
are undoubtedly other samples out there, and they are likely to be held at less
secure locations and discovered by clumsier and more nefarious individuals than
those roaming the halls of the NIH.
Additionally, it could always pop up in nature (you know, like it did in
the first place) either in the same form or a different strain from the same, still-existent
progenitors of variola.
What’s even less comforting is that it has a carrier that
will never die; the Internet. The
genome of smallpox (and many other deadly pathogens like the 1918 flu and
poliovirus) is freely available in online public databases. A quick web search shows that The
Guardian was able to obtain a strain of it through mail order. If you’re willing to pay a small rush
fee, there’s still time to order your favorite uncle a stocking-stuffer for Christmas! If a bad guy really wants to get his
mitts on a smallpox virus, he doesn’t have to break into the CDC, he can do it
from a public login at his local library.
Now that the myth of security has been debunked, it’s time
to look at the benefits the variola stocks can provide. While it’s true that the samples are
not necessary for making small-scale amounts of vaccines, they are still hugely
valuable in studying the mutation and evolution of viruses and in techniques
for developing new vaccines. For
example, the virological study of smallpox identified a genetic mutation found
in some people that gave them a marked resistance to smallpox coincidently also
gave them nearly complete immunity from HIV.
Ironically the appearance HIV is the biggest development in
the realm of infectious disease since the eradication of smallpox. The irony would turn tragic if
destroying the smallpox specimens cut off life-saving developments. But the virus is not limited to helping
with HIV studies, it is one of the most well followed virus strains, which
allows us to gain better insights about innumerable diseases, both infectious
and autoimmune. Given the minute
risks posed by housing the smallpox virus at a careful and secure facility like
the CDC, it would be reckless and foolish to cut off all future benefits by
destroying them.
No comments:
Post a Comment